CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival

AIMS: We hypothesised that CD1d expression in renal cell carcinoma (RCC) may play a role in modifying the host immune response. Our aims were to investigate the expression of CD1d and to correlate this with histopathology and clinical outcomes in a cohort study of patients with RCC. METHODS: Gene ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Tsung Wen, Goh, Fera Yiqian, Sim, Mei Yi, Huang, Hong Hong, Thike, Daw Aye Aye, Lim, Weng Khong, Teh, Bin Tean, Tan, Puay Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345982/
https://www.ncbi.nlm.nih.gov/pubmed/25477528
http://dx.doi.org/10.1136/jclinpath-2014-202735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345982/
https://www.ncbi.nlm.nih.gov/pubmed/25477528
http://dx.doi.org/10.1136/jclinpath-2014-202735

Ejemplares similares